Citigroup’s Landos Biopharma, Inc. Common Stock LABP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-52
| Closed | -$260 | – | 5122 |
|
|
2022
Q4 | $260 | Buy |
52
+2
| +4% | +$10 | ﹤0.01% | 4775 |
|
|
2022
Q3 | $0 | Sell |
50
-24
| -32% | – | ﹤0.01% | 5675 |
|
|
2022
Q2 | $1K | Sell |
74
-207
| -74% | -$2.8K | ﹤0.01% | 5333 |
|
|
2022
Q1 | $4K | Buy |
281
+36
| +15% | +$512 | ﹤0.01% | 5104 |
|
|
2021
Q4 | $12K | Buy |
245
+190
| +345% | +$9.31K | ﹤0.01% | 4758 |
|
|
2021
Q3 | $8K | Buy |
55
+24
| +77% | +$3.49K | ﹤0.01% | 4772 |
|
|
2021
Q2 | $4K | Sell |
31
-11
| -26% | -$1.42K | ﹤0.01% | 5209 |
|
|
2021
Q1 | $4K | Buy |
+42
| New | +$4K | ﹤0.01% | 5301 |
|